MMY2002 (SIRIUS):
Daratumumab monotherapy in
patients with treatment-refractory
multiple myeloma
An open-label, randomized, phase 2 trial
Lonial S, Weiss BM, Usmani SZ, et al. Lancet 2016;387(10027):1551-60.
Lonial S, Weiss BM, Usmani S, et al. Presented at: 2015 ASCO; May 29-June 2, 2015; Chicago, IL, USA
